Skip to main content
SpringerLink
Log in

Hyponatremia Induced by Drugs

  • Chapter
  • First Online:
Hyponatremia

Abstract

Medications make up one of the most frequent causes of hyponatremia. They may induce hyponatremia by affecting either the sodium and water homeostasis (diuretics) or the water homeostasis due to the syndrome of inappropriate secretion of antidiuretic hormone. Certain drugs (e.g., diuretics, psychotropic medications, anticonvulsants) have been implicated as established causes of hyponatremia. However, hyponatremia infrequently develops in the course of treatment with drugs used in everyday clinical practice including proton pump inhibitors, antibiotics, angiotensin-converting enzyme inhibitors, hypoglycemic agents and amiodarone. Proper diagnostic approach of patients with low serum sodium concentrations should involve a detailed medical history with special attention to the use of culprit medications. In cases of drug-induced hyponatremia, discontinuation of therapy with these agents and avoidance of readministration is fully warranted given that even mild hyponatremia can have adverse outcomes (increased mortality, cognition impairment, high risk of falls and fractures).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Liamis G, Milionis H, Elisaf M. A review of drug-induced hyponatremia. Am J Kidney Dis. 2008;52(1):144–53.

    Article  PubMed  CAS  Google Scholar 

  2. Chow KM, Szeto CC, Wong TY, Leung CB, Li PK. Risk factors for thiazide-induced hyponatraemia. QJM. 2003;96(12):911–7.

    Article  PubMed  CAS  Google Scholar 

  3. Liamis G, Christidis D, Alexandridis G, Bairaktari E, Madias NE, Elisaf M. Uric acid homeostasis in the evaluation of diuretic-induced hyponatremia. J Investig Med. 2007;55(1):36–44.

    Article  PubMed  CAS  Google Scholar 

  4. Spital A. Diuretic-induced hyponatremia. Am J Nephrol. 1999;19(4):447–52.

    Article  PubMed  CAS  Google Scholar 

  5. Friedman E, Shadel M, Halkin H, Farfel Z. Thiazide-induced hyponatremia. Reproducibility by single dose rechallenge and an analysis of pathogenesis. Ann Intern Med. 1989;110(1):24–30.

    Article  PubMed  CAS  Google Scholar 

  6. Ashraf N, Locksley R, Arieff AI. Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am J Med. 1981;70(6):1163–8.

    Article  PubMed  CAS  Google Scholar 

  7. Ashouri OS. Severe diuretic-induced hyponatremia in the elderly. A series of eight patients. Arch Intern Med. 1986;146(7):1355–7.

    Article  PubMed  CAS  Google Scholar 

  8. Sonnenblick M, Friedlander Y, Rosin AJ. Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. Chest. 1993;103(2):601–6.

    Article  PubMed  CAS  Google Scholar 

  9. Abramow M, Cogan E. Clinical aspects and pathophysiology of diuretic-induced hyponatremia. Adv Nephrol Necker Hosp. 1984;13:1–28.

    PubMed  CAS  Google Scholar 

  10. Clark BA, Shannon RP, Rosa RM, Epstein FH. Increased susceptibility to thiazide-induced hyponatremia in the elderly. J Am Soc Nephrol. 1994;5(4):1106–11.

    PubMed  CAS  Google Scholar 

  11. Pinnock CA. Hyponatraemia associated with hydrochlorothiazide treatment. Br Med J. 1978;1(6104):48.

    Article  PubMed  CAS  Google Scholar 

  12. Snyder NA, Feigal DW, Arieff AI. Hypernatremia in elderly patients. A heterogeneous, morbid, and iatrogenic entity. Ann Intern Med. 1987;107(3):309–19.

    Article  PubMed  CAS  Google Scholar 

  13. Fadel S, Karmali R, Cogan E. Safety of furosemide administration in an elderly woman recovered from thiazide-induced hyponatremia. Eur J Intern Med. 2009;20(1):30–4.

    Article  PubMed  CAS  Google Scholar 

  14. Chapman MD, Hanrahan R, McEwen J, Marley JE. Hyponatraemia and hypokalaemia due to indapamide. Med J Aust. 2002;176(5):219–21.

    PubMed  Google Scholar 

  15. Plante GE, Dessurault DL. Hypertension in elderly patients. A comparative study between indapamide and hydrochlorothiazide. Am J Med. 1988;84(1B):98–103.

    PubMed  CAS  Google Scholar 

  16. Yong TY, Huang JE, Lau SY, Li JY. Severe hyponatremia and other electrolyte disturbances associated with indapamide. Curr Drug Saf. 2011;6(3):134–7.

    Article  PubMed  CAS  Google Scholar 

  17. Handler J. Well tolerated spironolactone-related hyponatremia. J Clin Hypertens (Greenwich). 2008;10(4):317–21.

    Article  Google Scholar 

  18. Johnston C, Webb L, Daley J, Spathis GS. Hyponatraemia and Moduretic-grand mal seizures: a review. J R Soc Med. 1989;82(8):479–83.

    PubMed  CAS  Google Scholar 

  19. Dyckner T, Wester PO. Effects of magnesium infusions in diuretic induced hyponatraemia. Lancet. 1981;1(8220 Pt 1):585–6.

    Article  PubMed  CAS  Google Scholar 

  20. Vu T, Wong RF, Hamblin PS, Zajac JF, Grossmann MF. Patients presenting with severe hypotonic hyponatremia: etiological factors, assessment, and outcomes. Hosp Pract (Minneap). 2009;37(1):128–36.

    Article  Google Scholar 

  21. Clayton JA, Rodgers S, Blakey J, Avery A, Hall IP. Thiazide diuretic prescription and electrolyte abnormalities in primary care. Br J Clin Pharmacol. 2006;61(1):87–95.

    Article  PubMed  CAS  Google Scholar 

  22. Leung AA, Wright A, Pazo V, Karson A, Bates DW. Risk of thiazide-induced hyponatremia in patients with hypertension. Am J Med. 2011;124(11):1064–72.

    Article  PubMed  CAS  Google Scholar 

  23. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991;265(24):3255–64.

    Article  Google Scholar 

  24. Sharabi Y, Illan R, Kamari Y, Cohen H, Nadler M, Messerli FH, et al. Diuretic induced hyponatraemia in elderly hypertensive women. J Hum Hypertens. 2002;16(9):631–5.

    Article  PubMed  CAS  Google Scholar 

  25. Sonnenblick M, Algur N, Rosin A. Thiazide-induced hyponatremia and vasopressin release. Ann Intern Med. 1989;110(9):751.

    Article  PubMed  CAS  Google Scholar 

  26. Walker RM, Brown RS, Stoff JS. Role of renal prostaglandins during antidiuresis and water diuresis in man. Kidney Int. 1982;21(2):365–70.

    Article  PubMed  CAS  Google Scholar 

  27. Letmaier M, Painold A, Hall AK, Vergin H, Engel R, Konstantinidis A, et al. Hyponatraemia during psychopharmacological treatment: results of a drug surveillance programme. Int J Neuropsychopharmacol. 2011;22:1–10.

    Google Scholar 

  28. Jacob S, Spinler SA. Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults. Ann Pharmacother. 2006;40(9):1618–22.

    Article  PubMed  CAS  Google Scholar 

  29. Liamis G, Mitrogianni Z, Liberopoulos EN, Tsimihodimos V, Elisaf M. Electrolyte disturbances in patients with hyponatremia. Intern Med. 2007;46(11):685–90.

    Article  PubMed  Google Scholar 

  30. Lohr JW. Osmotic demyelination syndrome following correction of hyponatremia: association with hypokalemia. Am J Med. 1994;96(5):408–13.

    Article  PubMed  CAS  Google Scholar 

  31. Lien YH, Shapiro JI, Chan L. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis. J Clin Invest. 1991;88(1):303–9.

    Article  PubMed  CAS  Google Scholar 

  32. Berl T, Rastegar A. A patient with severe hyponatremia and hypokalemia: osmotic demyelination following potassium repletion. Am J Kidney Dis. 2010;55(4):742–8.

    Article  PubMed  Google Scholar 

  33. Meulendijks D, Mannesse CK, Jansen PA, van Marum RJ, Egberts TC. Antipsychotic-induced hyponatraemia: a systematic review of the published evidence. Drug Saf. 2010;33(2):101–14.

    Article  PubMed  CAS  Google Scholar 

  34. Luzecky MH, Burman KD, Schultz ER. The syndrome of inappropriate secretion of antidiuretic hormone associated with amitriptyline administration. South Med J. 1974;67(4):495–7.

    Article  PubMed  CAS  Google Scholar 

  35. ten Holt WL, van Iperen CE, Schrijver G, Bartelink AK. Severe hyponatremia during therapy with fluoxetine. Arch Intern Med. 1996;156(6):681–2.

    Article  PubMed  CAS  Google Scholar 

  36. Jackson C, Carson W, Markowitz J, Mintzer J. SIADH associated with fluoxetine and sertraline therapy. Am J Psychiatry. 1995;152(5):809–10.

    PubMed  CAS  Google Scholar 

  37. Liu BA, Mittmann N, Knowles SR, Shear NH. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports. CMAJ. 1996;155(5):519–27.

    PubMed  CAS  Google Scholar 

  38. Movig KL, Leufkens HG, Lenderink AW, van den Akker VG, Hodiamont PP, Goldschmidt HM, et al. Association between antidepressant drug use and hyponatraemia: a case-control study. Br J Clin Pharmacol. 2002;53(4):363–9.

    Article  PubMed  CAS  Google Scholar 

  39. Vincent FM, Emery S. Antidiuretic hormone syndrome and thioridazine. Ann Intern Med. 1978;89(1):147–8.

    Article  PubMed  CAS  Google Scholar 

  40. Peterson JC, Pollack RW, Mahoney JJ, Fuller TJ. Inappropriate antidiuretic hormone secondary to a monamine oxidase inhibitor. JAMA. 1978;239(14):1422–3.

    Article  PubMed  CAS  Google Scholar 

  41. Rao KJ, Miller M, Moses A. Water intoxication and thioridazine (Mellaril). Ann Intern Med. 1975;82(1):61.

    Article  PubMed  CAS  Google Scholar 

  42. Peck V, Shenkman L. Haloperidol-induced syndrome of inappropriate secretion of antidiuretic hormone. Clin Pharmacol Ther. 1979;26(4):442–4.

    PubMed  CAS  Google Scholar 

  43. Siegel AJ. Hyponatremia in psychiatric patients: update on evaluation and management. Harv Rev Psychiatry. 2008;16(1):13–24.

    Article  PubMed  Google Scholar 

  44. Ranieri P, Franzoni S, Rozzini R, Trabucchi M. Venlafaxine-induced reset osmostat syndrome: case of a 79-year-old depressed woman. J Geriatr Psychiatry Neurol. 1997;10(2):75–8.

    PubMed  CAS  Google Scholar 

  45. Raskind MA, Orenstein H, Christopher TG. Acute psychosis, increased water ingestion, and inappropriate antidiuretic hormone secretion. Am J Psychiatry. 1975;132(9):907–10.

    PubMed  CAS  Google Scholar 

  46. Jose CJ, Perez-Cruet J. Incidence and morbidity of self-induced water intoxication in state mental hospital patients. Am J Psychiatry. 1979;136(2):221–2.

    PubMed  CAS  Google Scholar 

  47. Illowsky BP, Kirch DG. Polydipsia and hyponatremia in psychiatric patients. Am J Psychiatry. 1988;145(6):675–83.

    PubMed  CAS  Google Scholar 

  48. Dundas B, Harris M, Narasimhan M. Psychogenic polydipsia review: etiology, differential, and treatment. Curr Psychiatry Rep. 2007;9(3):236–41.

    Article  PubMed  Google Scholar 

  49. Palmer BF, Gates JR, Lader M. Causes and management of hyponatremia. Ann Pharmacother. 2003;37(11):1694–702.

    Article  PubMed  Google Scholar 

  50. Engel WR, Grau A. Inappropriate secretion of antidiuretic hormone associated with lorazepam. BMJ. 1988;297(6652):858.

    Article  PubMed  CAS  Google Scholar 

  51. Yamaguchi K, Hama H. Changes in vasopressin release and autonomic function induced by manipulating forebrain GABAergic signaling under euvolemia and hypovolemia in conscious rats. Endocr J. 2011;58(7):559–73.

    Article  PubMed  CAS  Google Scholar 

  52. Meinders AE, Cejka V, Robertson GL. The antidiuretic action of carbamazepine in man. Clin Sci Mol Med. 1974;47(4):289–99.

    PubMed  CAS  Google Scholar 

  53. Gold PW, Robertson GL, Ballenger JC, Kaye W, Chen J, Rubinow DR, et al. Carbamazepine diminishes the sensitivity of the plasma arginine vasopressin response to osmotic stimulation. J Clin Endocrinol Metab. 1983;57(5):952–7.

    Article  PubMed  CAS  Google Scholar 

  54. Flegel KM, Cole CH. Inappropriate antidiuresis during carbamazepine treatment. Ann Intern Med. 1977;87(6):722–3.

    Article  PubMed  CAS  Google Scholar 

  55. Van Amelsvoort T, Bakshi R, Devaux CB, Schwabe S. Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review. Epilepsia. 1994;35(1):181–8.

    Article  PubMed  Google Scholar 

  56. Kuz GM, Manssourian A. Carbamazepine-induced hyponatremia: assessment of risk factors. Ann Pharmacother. 2005;39(11):1943–6.

    Article  PubMed  Google Scholar 

  57. Holtschmidt-Taschner B, Soyka M. Hyponatremia-induced seizure during carbamazepine treatment. World J Biol Psychiatry. 2007;8(1):51–3.

    Article  PubMed  Google Scholar 

  58. de Braganca AC, Moyses ZP, Magaldi AJ. Carbamazepine can induce kidney water absorption by increasing aquaporin 2 expression. Nephrol Dial Transplant. 2010;25(12):3840–5.

    Article  PubMed  CAS  Google Scholar 

  59. Nielsen OA, Johannessen AC, Bardrum B. Oxcarbazepine-induced hyponatremia, a cross-sectional study. Epilepsy Res. 1988;2(4):2697–1.

    Article  Google Scholar 

  60. Wellington K, Goa KL. Oxcarbazepine: an update of its efficacy in the management of epilepsy. CNS Drugs. 2001;15(2):137–63.

    Article  PubMed  CAS  Google Scholar 

  61. Lin CH, Lu CH, Wang FJ, Tsai MH, Chang WN, Tsai NW, et al. Risk factors of oxcarbazepine-induced hyponatremia in patients with epilepsy. Clin Neuropharmacol. 2010;33(6):293–6.

    Article  PubMed  CAS  Google Scholar 

  62. Beers E, van Puijenbroek EP, Bartelink IH, van der Linden CM, Jansen PA. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) or hyponatraemia associated with valproic Acid: four case reports from the Netherlands and a case/non-case analysis of vigibase. Drug Saf. 2010;33(1):47–55.

    Article  PubMed  CAS  Google Scholar 

  63. Nasrallah K, Silver B. Hyponatremia associated with repeated use of levetiracetam. Epilepsia. 2005;46(6):972–3.

    Article  PubMed  Google Scholar 

  64. Mewasingh L, Aylett S, Kirkham F, Stanhope R. Hyponatraemia associated with lamotrigine in cranial diabetes insipidus. Lancet. 2000;356(9230):656.

    Article  PubMed  CAS  Google Scholar 

  65. Bressler RB, Huston DP. Water intoxication following moderate-dose intravenous cyclophosphamide. Arch Intern Med. 1985;145(3):548–9.

    Article  PubMed  CAS  Google Scholar 

  66. Bode U, Seif SM, Levine AS. Studies on the antidiuretic effect of cyclophosphamide: vasopressin release and sodium excretion. Med Pediatr Oncol. 1980;8(3):295–303.

    Article  PubMed  CAS  Google Scholar 

  67. Robertson GL, Bhoopalam N, Zelkowitz LJ. Vincristine neurotoxicity and abnormal secretion of antidiuretic hormone. Arch Intern Med. 1973;132(5):717–20.

    Article  PubMed  CAS  Google Scholar 

  68. Ravikumar TS, Grage TB. The syndrome of inappropriate ADH secretion secondary to vinblastine-bleomycin therapy. J Surg Oncol. 1983;24(3):242–5.

    Article  PubMed  CAS  Google Scholar 

  69. Raftopoulos H. Diagnosis and management of hyponatremia in cancer patients. Support Care Cancer. 2007;15(12):1341–7.

    Article  PubMed  Google Scholar 

  70. Berghmans T. Hyponatremia related to medical anticancer treatment. Support Care Cancer. 1996;4(5):341–50.

    Article  PubMed  CAS  Google Scholar 

  71. Hammond IW, Ferguson JA, Kwong K, Muniz E, Delisle F. Hyponatremia and syndrome of inappropriate anti-diuretic hormone reported with the use of Vincristine: an over-representation of Asians? Pharmacoepidemiol Drug Saf. 2002;11(3):229–34.

    Article  PubMed  CAS  Google Scholar 

  72. Lee YK, Shin DM. Renal salt wasting in patients treated with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small cell lung cancer. Korean J Intern Med. 1992;7(2):118–21.

    PubMed  CAS  Google Scholar 

  73. Ritch PS. Cis-dichlorodiammineplatinum II-induced syndrome of inappropriate secretion of antidiuretic hormone. Cancer. 1988;61(3):448–50.

    Article  PubMed  CAS  Google Scholar 

  74. Giaccone G, Donadio M, Ferrati P, Ciuffreda L, Bagatella M, Gaddi M, et al. Disorders of serum electrolytes and renal function in patients treated with cis-platinum on an outpatient basis. Eur J Cancer Clin Oncol. 1985;21(4):433–7.

    Article  PubMed  CAS  Google Scholar 

  75. Bagchi S, Husain Zaidi S, Prasad MR. Severe symptomatic hyponatremia – an uncommon presentation of tacrolimus nephrotoxicity. Nephrol Dial Transplant. 2011;26(6):2042–4.

    Article  PubMed  CAS  Google Scholar 

  76. Frahm H, von Hulst M. [Increased secretion of vasopressin and edema formation in high dosage methotrexate therapy]. Z Gesamte Inn Med. 1988;43(15):411–4.

    PubMed  CAS  Google Scholar 

  77. Beukhof CM, Hoorn EJ, Lindemans J, Zietse R. Novel risk factors for hospital-acquired hyponatraemia: a matched case-control study. Clin Endocrinol (Oxf). 2007;66(3):367–72.

    Article  Google Scholar 

  78. Langfeldt LA, Cooley ME. Syndrome of inappropriate antidiuretic hormone secretion in malignancy: review and implications for nursing management. Clin J Oncol Nurs. 2003;7(4):425–30.

    Article  PubMed  Google Scholar 

  79. Budisavljevic MN, Stewart L, Sahn SA, Ploth DW. Hyponatremia associated with 3,4-methylenedioxymethylamphetamine (“Ecstasy”) abuse. Am J Med Sci. 2003;326(2):89–93.

    Article  PubMed  Google Scholar 

  80. Holden R, Jackson MA. Near-fatal hyponatraemic coma due to vasopressin over-secretion after “ecstasy” (3,4-MDMA). Lancet. 1996;347(9007):1052.

    Article  PubMed  CAS  Google Scholar 

  81. Wilkins B. Cerebral oedema after MDMA (“ecstasy”) and unrestricted water intake. Hyponatraemia must be treated with low water input. BMJ. 1996;313(7058):689–90.

    Article  PubMed  CAS  Google Scholar 

  82. Izzedine H, Fardet L, Launay-Vacher V, Dorent R, Petitclerc T, Deray G. Angiotensin-converting enzyme inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone: case report and review of the literature. Clin Pharmacol Ther. 2002;71(6):503–7.

    Article  PubMed  Google Scholar 

  83. Shavit E, Sherer Y. Hyponatremia induced by amiodarone therapy. Isr Med Assoc J. 2007;9(7):564–5.

    PubMed  Google Scholar 

  84. Singla S, Strobel AL, Deshmukh AJ, Paydak H. Amiodarone-related hyponatremia: rare but potentially lethal. Am J Ther. 2011 [Epub ahead of print].

    Google Scholar 

  85. Somani P, Temesy-Armos PN, Leighton RF, Goodenday LS, Fraker Jr TD. Hyponatremia in patients treated with lorcainide, a new antiarrhythmic drug. Am Heart J. 1984;108(6):1443–8.

    Article  PubMed  CAS  Google Scholar 

  86. Dirix LY, Moeremans C, Fierens H, Dielen D, Vrints C, Van Agt E, et al. Symptomatic hyponatremia related to the use of propafenone. Acta Clin Belg. 1988;43(2):143–5.

    PubMed  CAS  Google Scholar 

  87. Zietse R, Zoutendijk R, Hoorn EJ. Fluid, electrolyte and acid-base disorders associated with antibiotic therapy. Nat Rev Nephrol. 2009;5(4):193–202.

    Article  PubMed  CAS  Google Scholar 

  88. Mori H, Kuroda Y, Imamura S, Toyoda A, Yoshida I, Kawakami M, et al. Hyponatremia and/or hyperkalemia in patients treated with the standard dose of trimethoprim-sulfamethoxazole. Intern Med. 2003;42(8):665–9.

    Article  PubMed  CAS  Google Scholar 

  89. Yeung KT, Chan M, Chan CK. The safety of i.v. pentamidine administered in an ambulatory setting. Chest. 1996;110(1):136–40.

    Article  PubMed  CAS  Google Scholar 

  90. Bevilacqua M. Hyponatraemia in AIDS. Baillieres Clin Endocrinol Metab. 1994;8(4):837–48.

    Article  PubMed  CAS  Google Scholar 

  91. Adler D, Voide C, Thorens JB, Desmeules J. SIADH consecutive to ciprofloxacin intake. Eur J Intern Med. 2004;15(7):463–4.

    Article  PubMed  Google Scholar 

  92. Chitre MM, Berenson CS. Idiosyncratic rifabutin-induced leukopenia and SIADH: case report and review. Pharmacotherapy. 2001;21(4):493–7.

    Article  PubMed  CAS  Google Scholar 

  93. Arzuaga JA, Estirado E, Roman F, Perez-Maestu R, Masa C, de Letona JM. Syndrome of inappropriate antidiuretic hormone secretion and herpes zoster infection: 1. Report of this association in a patient suffering from AIDS. Nephron. 1994;68(2):262–4.

    Article  PubMed  CAS  Google Scholar 

  94. Semel JD, McNerney Jr JJ. SIADH during disseminated Herpes varicella-zoster infections: relationship to vidarabine therapy. Am J Med Sci. 1986;291(2):115–8.

    Article  PubMed  CAS  Google Scholar 

  95. Teranishi J, Nagatoya K, Kakita T, Yamauchi Y, Matsuda H, Mori T, et al. Voriconazole-associated salt-losing nephropathy. Clin Exp Nephrol. 2010;14(4):377–80.

    Article  PubMed  CAS  Google Scholar 

  96. Mitra S, Basu S. Cefoperazone/sulbactam induced hyponatremia. Indian J Med Sci. 2006;60(4):158–9.

    Article  PubMed  Google Scholar 

  97. Stevens DA. Miconazole in the treatment of coccidioidomycosis. Drugs. 1983;26(4):347–54.

    Article  PubMed  CAS  Google Scholar 

  98. Suzuki H, Sugimura Y, Iwama S, Nobuaki O, Nagasaki H, Arima H, et al. Minocycline prevents osmotic demyelination syndrome by inhibiting the activation of microglia. J Am Soc Nephrol. 2010;21(12):2090–8.

    Article  PubMed  CAS  Google Scholar 

  99. Gankam-Kengne F, Soupart A, Pochet R, Brion JP, Decaux G. Minocycline protects against neurologic complications of rapid correction of hyponatremia. J Am Soc Nephrol. 2010;21(12):2099–108.

    Article  PubMed  CAS  Google Scholar 

  100. Brewster UC, Perazella MA. Proton pump inhibitors and the kidney: critical review. Clin Nephrol. 2007;68(2):65–72.

    PubMed  CAS  Google Scholar 

  101. Liberopoulos EN, Alexandridis GH, Christidis DS, Elisaf MS. SIADH and hyponatremia with theophylline. Ann Pharmacother. 2002;36(7–8):1180–2.

    Article  PubMed  Google Scholar 

  102. Weissman PN, Shenkman L, Gregerman RI. Chlorpropamide hyponatremia: drug-induced inappropriate antidiuretic-hormone activity. N Engl J Med. 1971;284(2):65–71.

    Article  PubMed  CAS  Google Scholar 

  103. Kadowaki T, Hagura R, Kajinuma H, Kuzuya N, Yoshida S. Chlorpropamide-induced hyponatremia: incidence and risk factors. Diabet Care. 1983;6(5):468–71.

    Article  CAS  Google Scholar 

  104. Moses AM, Howanitz J, Miller M. Diuretic action of three sulfonylurea drugs. Ann Intern Med. 1973;78(4):541–4.

    Article  PubMed  CAS  Google Scholar 

  105. Moses AM, Fenner R, Schroeder ET, Coulson R. Further studies on the mechanism by which chlorpropamide alters the action of vasopressin. Endocrinology. 1982;111(6):2025–30.

    Article  PubMed  CAS  Google Scholar 

  106. Bustamante M, Hasler U, Kotova O, Chibalin AV, Mordasini D, Rousselot M, et al. Insulin potentiates AVP-induced AQP2 expression in cultured renal collecting duct principal cells. Am J Physiol Renal Physiol. 2005;288(2):F334–44.

    Article  PubMed  CAS  Google Scholar 

  107. Berker D, Aydin Y, Arduc A, Ustun I, Ergun B, Guler S. Severe hyponatremia due to rosiglitazone use in an elderly woman with diabetes mellitus: a rare cause of syndrome of inappropriate antidiuretic hormone secretion. Endocr Pract. 2008;14(8):1017–9.

    Article  PubMed  Google Scholar 

  108. Petersson I, Nilsson G, Hansson BG, Hedner T. Water intoxication associated with non-steroidal anti-inflammatory drug therapy. Acta Med Scand. 1987;221(2):221–3.

    Article  PubMed  CAS  Google Scholar 

  109. Webberley MJ, Murray JA. Life-threatening acute hyponatraemia induced by low dose cyclophosphamide and indomethacin. Postgrad Med J. 1989;65(770):950–2.

    Article  PubMed  CAS  Google Scholar 

  110. Schwartz RH, Jones RW. Transplacental hyponatraemia due to oxytocin. Br Med J. 1978;1(6106):152–3.

    Article  PubMed  CAS  Google Scholar 

  111. Feeney JG. Water intoxication and oxytocin. Br Med J (Clin Res Ed). 1982;285(6337):243.

    Article  CAS  Google Scholar 

  112. Shepherd LL, Hutchinson RJ, Worden EK, Koopmann CF, Coran A. Hyponatremia and seizures after intravenous administration of desmopressin acetate for surgical hemostasis. J Pediatr. 1989;114(3):470–2.

    Article  PubMed  CAS  Google Scholar 

  113. Humphries JE, Siragy H. Significant hyponatremia following DDAVP administration in a healthy adult. Am J Hematol. 1993;44(1):12–5.

    Article  PubMed  CAS  Google Scholar 

  114. Sola E, Lens S, Guevara M, Martin-Llahi M, Fagundes C, Pereira G, et al. Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension. Hepatology. 2010;52(5):1783–90.

    Article  PubMed  CAS  Google Scholar 

  115. Palevsky PM, Rendulic D, Diven WF. Maltose-induced hyponatremia. Ann Intern Med. 1993;118(7):526–8.

    Article  PubMed  CAS  Google Scholar 

  116. Daphnis E, Stylianou K, Alexandrakis M, Xylouri I, Vardaki E, Stratigis S, et al. Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy. Nephron Clin Pract. 2007;106(4):c143–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, School of Medicine, University of Ioannina, Ioannina, Greece

    George Liamis M.D. & Moses Elisaf M.D.

Authors
  1. George Liamis M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Moses Elisaf M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to George Liamis M.D. .

Editor information

Editors and Affiliations

  1. Section of Nephrology and Hypertension, Tulane University Health Sciences Center, Tulane Ave 1430, New Orleans, 70112, Louisiana, USA

    Eric E. Simon

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Liamis, G., Elisaf, M. (2013). Hyponatremia Induced by Drugs. In: Simon, E. (eds) Hyponatremia. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6645-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6645-1_6

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6644-4

  • Online ISBN: 978-1-4614-6645-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation